234
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Analysing Home Pharmaceutical Care Under the Combination of Medical Care and Nursing

, , , &
Pages 1793-1800 | Received 07 Mar 2023, Accepted 30 May 2023, Published online: 27 Jun 2023
 

Abstract

Objective

Home pharmaceutical care delivers individualised, whole-process and continuous pharmaceutical services and health education. This study aims to explore the feasibility of home pharmaceutical services as a combination of medical and nursing care.

Methods

Patient information was collected from 1 October 2020 to 30 September 2021 and was analysed and evaluated. We then developed a family medication plan and investigated its effectiveness and any issues encountered during the implementation process.

Results

A total of 102 patients received services, and 100% of the patients were satisfied with these. Moreover, using home pharmaceutical care saved approximately USD1,359.64 (RMB9,360.45) in outpatient costs and USD41,077.76 (RMB282,700) in inpatient costs, and the number of hospitalisations was reduced by 16%.

Conclusion

It is beneficial to make home pharmaceutical services available as a combination of medical and nursing care. Pharmacists can help patients solve medication-related problems and reduce the number of hospitalisations and medical costs through standardised service models while ensuring safe, effective, economical and rational drug use for patients.

Data Sharing Statement

All data generated or analyzed during this study are included in this published article.

Ethics Approval and Consent to Participate

This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Hebei Yanda Hospital. Written informed consent was obtained from all participants.

Disclosure

All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.

Additional information

Funding

Hebei Pharmaceutical Society Hospital Pharmaceutical Research Special Project (2020-Hbsyxhqn0034).